Company Active LTD

Company profile

Centauri Therapeutics Limited

Immunotherapy focused on infectious diseases - Centauri Therapeutics Limited

At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.

CRN
08879741
Founded
2014
Age
12

Overview

Legal name
CENTAURI THERAPEUTICS LIMITED
Region
London
Registered address
FIRST FLOOR
5 FLEET PLACE
LONDON
UNITED KINGDOM
EC4M 7RD
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
12

Company events

Reference milestones and recent Companies House filing stream events.

5 events
20 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

06 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

06 Feb
2014

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2017
Funded years
2017
Age at first award
3 years

Projects

2017 Collaborative R&D Lead participant

Optimisation of Antibody Recruiting Molecules as Immunotherapeutics

1 Aug 2017 to 31 Jul 2019

Awarded
£945,039
Total cost £1,350,055

Antibiotics have revolutionised healthcare but bacteria continually evolve to resist new medicines. The lack of new antibiotics combined with increasing incidence of resistance in the clinic has been termed ‘the perfect storm’ and there is an urgent need for new therapies. Our project will deliver a novel treatment for patients suffering from infections c...

Product types

Collaborative R&D